TOPS vs Fusion: New Study Confirms Superiority

Superiority in any given surgery for any given device is one of the rarest, most elusive FDA designations available to medical device companies. In the world of treating single-level lumbar spinal stenosis and grade-I degenerative spondylolisthesis, only one manufacturer has ever achieved a superiority claim—that company is Premia Spine, and the implant is the Total Posterior Spine System (TOPS).

In the June 19, 2024, edition of The Journal of Bone and Joint Surgery, researchers published updated data from the FDA study which not only reaffirms TOPS superiority over fusion but added more depth and understanding as to why that is the case.